ROCURONIUM BROMIDE

ROCURONIUM BROMIDE was reported 12126 times

ROCURONIUM BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RECURRENCE OF NEUROMUSCULAR BLOCKADE 103 0.6023
1 NEGATIVE PRESSURE PULMONARY OEDEMA 53 0.5408
2 TRIGEMINO-CARDIAC REFLEX 33 0.4074
3 NEUROMUSCULAR BLOCK PROLONGED 150 0.4065
4 AIRWAY PEAK PRESSURE INCREASED 59 0.3882
5 ANAESTHETIC COMPLICATION NEUROLOGICAL 270 0.2980
6 END-TIDAL CO2 INCREASED 13 0.2826
7 NEUROMUSCULAR BLOCKING THERAPY 9 0.2727
8 NEUROMUSCULAR BLOCKADE 61 0.2723
9 MECHANICAL VENTILATION COMPLICATION 38 0.2550
10 MYOGLOBIN URINE PRESENT 62 0.2520
11 BLOOD BROMIDE INCREASED 5 0.2381
12 CHEST WALL RIGIDITY 12 0.1875
13 AIRWAY COMPLICATION OF ANAESTHESIA 42 0.1597
14 ISOIMMUNE HAEMOLYTIC DISEASE 6 0.1579
15 ANAESTHETIC COMPLICATION PULMONARY 14 0.1573
16 PSEUDOCHOLINESTERASE DEFICIENCY 10 0.1538
17 HYPERTHERMIA MALIGNANT 219 0.1471
18 TRYPTASE DECREASED 7 0.1373
19 BURKHOLDERIA TEST POSITIVE 17 0.1371
20 DELAYED RECOVERY FROM ANAESTHESIA 129 0.1361
21 CATECHOLAMINE CRISIS 5 0.1351
22 POSTOPERATIVE DELIRIUM 23 0.1162
23 END-TIDAL CO2 DECREASED 5 0.1064
24 COVID-19 TREATMENT 7 0.1029
25 UNWANTED AWARENESS DURING ANAESTHESIA 33 0.1006
26 INSPIRATORY CAPACITY DECREASED 26 0.0939
27 PROCEDURAL HYPOTENSION 77 0.0905
28 OESOPHAGEAL INTRAMURAL HAEMATOMA 8 0.0762
29 THERAPEUTIC RESPONSE PROLONGED 7 0.0745
30 FIBRINOLYSIS 5 0.0735
31 CARCINOID CRISIS 16 0.0708
32 VENTRICULAR ASYSTOLE 11 0.0632
33 ACCELERATED IDIOVENTRICULAR RHYTHM 9 0.0608
34 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 5 0.0595
35 ENDOTRACHEAL INTUBATION COMPLICATION 35 0.0593
36 CONGENITAL BLADDER ANOMALY 8 0.0593
37 ANAESTHETIC COMPLICATION CARDIAC 4 0.0580
38 ALLERGY TEST NEGATIVE 9 0.0577
39 POSTOPERATIVE RESPIRATORY FAILURE 6 0.0577
40 APGAR SCORE ABNORMAL 6 0.0566
41 DRUG EFFECT PROLONGED 31 0.0562
42 ATRIOVENTRICULAR DISSOCIATION 12 0.0561
43 PULMONARY HYPERTENSIVE CRISIS 15 0.0554
44 SUBDURAL EFFUSION 5 0.0543
45 FOETAL ANAEMIA 7 0.0534
46 BASAL GANGLION DEGENERATION 5 0.0532
47 HYPERDYNAMIC LEFT VENTRICLE 13 0.0528
48 MATERNAL EXPOSURE DURING DELIVERY 50 0.0505
49 ALKALOSIS HYPOCHLORAEMIC 7 0.0500
50 TRACHEAL INJURY 7 0.0476
51 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 18 0.0474
52 BRACHIAL PLEXOPATHY 10 0.0452
53 SKIN TEST POSITIVE 42 0.0450
54 MYOCARDIAL STUNNING 6 0.0448
55 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 5 0.0446
56 THERAPEUTIC PRODUCT EFFECT PROLONGED 20 0.0442
57 POST PROCEDURAL STROKE 8 0.0435
58 VOCAL CORD DYSFUNCTION 21 0.0426
59 FEEDING INTOLERANCE 19 0.0421
60 ANAPHYLACTIC SHOCK 1073 0.0416
61 KOUNIS SYNDROME 94 0.0414
62 CENTRAL VENOUS PRESSURE INCREASED 5 0.0410
63 HEPARIN RESISTANCE 5 0.0410
64 BLOOD CATECHOLAMINES INCREASED 5 0.0400
65 WRIST SURGERY 37 0.0396
66 NECROTISING SOFT TISSUE INFECTION 9 0.0390
67 PHAEOCHROMOCYTOMA CRISIS 8 0.0377
68 RESPIRATORY PARALYSIS 6 0.0375
69 MYOTONIA 8 0.0360
70 HYPOCAPNIA 15 0.0359
71 CORONARY ARTERY EMBOLISM 10 0.0338
72 PARKINSONISM HYPERPYREXIA SYNDROME 6 0.0335
73 NEONATAL RESPIRATORY DEPRESSION 11 0.0331
74 ALLERGIC TRANSFUSION REACTION 5 0.0331
75 LARYNGEAL OBSTRUCTION 6 0.0328
76 SPINAL CORD OEDEMA 12 0.0324
77 TENDON OPERATION 15 0.0311
78 FOETAL EXPOSURE DURING DELIVERY 20 0.0295
79 ALLERGY TEST POSITIVE 13 0.0287
80 CHEYNE-STOKES RESPIRATION 7 0.0282
81 PULSELESS ELECTRICAL ACTIVITY 117 0.0280
82 ANAPHYLACTOID SHOCK 13 0.0277
83 HYPOVENTILATION 88 0.0270
84 BRONCHOSPASM 385 0.0270
85 PROPOFOL INFUSION SYNDROME 19 0.0270
86 SICK LEAVE 6 0.0267
87 TRYPTASE INCREASED 19 0.0266
88 PROCEDURAL VOMITING 17 0.0262
89 DIABETES INSIPIDUS 61 0.0253
90 VENTRICULAR DYSKINESIA 5 0.0240
91 ANAPHYLACTIC REACTION 1326 0.0240
92 ANAESTHETIC COMPLICATION 64 0.0238
93 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 25 0.0235
94 RESPIRATORY ACIDOSIS 92 0.0234
95 ACUTE CARDIAC EVENT 4 0.0233
96 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 8 0.0230
97 MYXOEDEMA COMA 7 0.0230
98 HYPERCAPNIA 69 0.0229
99 SPINAL CORD INFARCTION 10 0.0227
100 SUBCUTANEOUS EMPHYSEMA 22 0.0224
101 GLASGOW COMA SCALE ABNORMAL 8 0.0218
102 AIR EMBOLISM 10 0.0212
103 NEONATAL ASPHYXIA 15 0.0212
104 STRESS CARDIOMYOPATHY 120 0.0206
105 BRADYCARDIA FOETAL 17 0.0205
106 LARYNGOSPASM 54 0.0201
107 CIRCUMORAL OEDEMA 7 0.0201
108 MEAN ARTERIAL PRESSURE DECREASED 5 0.0198
109 ANTICHOLINERGIC SYNDROME 31 0.0194
110 COMPLICATIONS OF TRANSPLANTED LIVER 7 0.0194
111 MYOCARDIAL DEPRESSION 5 0.0194
112 CARDIAC OUTPUT DECREASED 17 0.0193
113 WEANING FAILURE 7 0.0192
114 VASOPLEGIA SYNDROME 31 0.0189
115 LIMB REDUCTION DEFECT 11 0.0188
116 PROCEDURAL NAUSEA 15 0.0186
117 SCROTAL ABSCESS 7 0.0185
118 SINUS ARREST 29 0.0185
119 TENOSYNOVITIS 50 0.0181
120 AMYLASE INCREASED 65 0.0176
121 IRREGULAR BREATHING 10 0.0170
122 SPINAL EPIDURAL HAEMATOMA 10 0.0170
123 UPPER AIRWAY OBSTRUCTION 15 0.0169
124 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 56 0.0169
125 MYASTHENIC SYNDROME 13 0.0168
126 APGAR SCORE LOW 21 0.0163
127 RESPIRATORY MUSCLE WEAKNESS 5 0.0154
128 HAEMODYNAMIC INSTABILITY 117 0.0153
129 MYOCARDIAL OEDEMA 6 0.0152
130 PNEUMOCEPHALUS 5 0.0151
131 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 33 0.0150
132 LUNG PERFORATION 5 0.0149
133 ELECTROCARDIOGRAM T WAVE PEAKED 6 0.0149
134 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 39 0.0149
135 TOXIC ENCEPHALOPATHY 74 0.0146
136 THYROTOXIC CRISIS 16 0.0141
137 OROMANDIBULAR DYSTONIA 10 0.0137
138 OPERATIVE HAEMORRHAGE 6 0.0134
139 SPIROMETRY ABNORMAL 8 0.0134
140 NEURODEVELOPMENTAL DISORDER 9 0.0133
141 ANISOCORIA 5 0.0132
142 LUMBAR PUNCTURE 5 0.0132
143 ARTERIOSPASM CORONARY 52 0.0129
144 CEREBRAL HYPOPERFUSION 6 0.0129
145 CIRCULATORY COLLAPSE 217 0.0127
146 ELECTROCARDIOGRAM ST-T CHANGE 9 0.0127
147 TRACHEOMALACIA 5 0.0127
148 PCO2 INCREASED 9 0.0126
149 SEROTONIN SYNDROME 241 0.0125
150 ELECTROMECHANICAL DISSOCIATION 10 0.0125
151 ENDOTRACHEAL INTUBATION 35 0.0125
152 GENITAL ABSCESS 5 0.0124
153 PRINZMETAL ANGINA 12 0.0121
154 PRODUCT MEASURED POTENCY ISSUE 12 0.0119
155 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 13 0.0118
156 DIAPHRAGMATIC PARALYSIS 7 0.0117
157 PUPIL FIXED 20 0.0115
158 BRONCHOPULMONARY DYSPLASIA 9 0.0112
159 ABDOMINAL COMPARTMENT SYNDROME 7 0.0110
160 RIGHT VENTRICULAR DYSFUNCTION 12 0.0109
161 RESUSCITATION 18 0.0108
162 RESPIRATORY TRACT OEDEMA 8 0.0108
163 PSYCHOGENIC SEIZURE 10 0.0107
164 SUPERFICIAL VEIN THROMBOSIS 9 0.0107
165 PULMONARY VASCULAR DISORDER 5 0.0106
166 VENTRICULAR FIBRILLATION 117 0.0105
167 FINGER DEFORMITY 51 0.0105
168 LARYNGEAL STENOSIS 6 0.0104
169 APNOEA 80 0.0103
170 GRIMACING 8 0.0102
171 TYPE I HYPERSENSITIVITY 36 0.0102
172 ACIDOSIS HYPERCHLORAEMIC 6 0.0101
173 PULMONARY ALVEOLAR HAEMORRHAGE 56 0.0100
174 CLONUS 27 0.0099
175 TROPONIN INCREASED 74 0.0097
176 COAGULATION TIME PROLONGED 15 0.0097
177 NON-CARDIOGENIC PULMONARY OEDEMA 10 0.0095
178 CYANOSIS NEONATAL 6 0.0094
179 PARAPLEGIA 27 0.0093
180 ANAPHYLACTOID REACTION 38 0.0092
181 RESPIRATORY DEPRESSION 113 0.0092
182 PUPILLARY REFLEX IMPAIRED 17 0.0092
183 BREAST CANCER RECURRENT 29 0.0092
184 BRONCHOSTENOSIS 5 0.0091
185 HAEMOTHORAX 26 0.0090
186 SUBSTANCE DEPENDENCE 6 0.0089
187 HYPERREFLEXIA 31 0.0089
188 ANENCEPHALY 5 0.0088
189 OPISTHOTONUS 7 0.0088
190 THERAPEUTIC PRODUCT EFFECT INCREASED 10 0.0086
191 HYPOPERFUSION 9 0.0086
192 FANCONI SYNDROME 12 0.0085
193 SINOATRIAL BLOCK 5 0.0084
194 RESPIRATORY TRACT HAEMORRHAGE 5 0.0084
195 DISSOCIATIVE DISORDER 6 0.0083
196 CARDIAC ARREST 685 0.0083
197 TORSADE DE POINTES 64 0.0081
198 HYPOXIA 281 0.0080
199 VENTRICULAR TACHYCARDIA 130 0.0079
200 ELECTROCARDIOGRAM PR PROLONGATION 6 0.0078
201 THERAPEUTIC PRODUCT CROSS-REACTIVITY 7 0.0078
202 BRONCHIAL OBSTRUCTION 11 0.0078
203 LIMB OPERATION 37 0.0077
204 HYPERMAGNESAEMIA 5 0.0077
205 BRADYCARDIA 404 0.0076
206 PHAEOCHROMOCYTOMA 5 0.0076
207 LYMPHOCELE 5 0.0075
208 ACIDOSIS 57 0.0075
209 INCREASED BRONCHIAL SECRETION 19 0.0074
210 POSTPARTUM HAEMORRHAGE 10 0.0074
211 INFANTILE APNOEA 6 0.0074
212 CARBON DIOXIDE INCREASED 10 0.0073
213 BRADYARRHYTHMIA 12 0.0073
214 AMAUROSIS 6 0.0071
215 ADRENAL SUPPRESSION 6 0.0071
216 MYOCARDIAL INJURY 8 0.0071
217 HYPOTONIA NEONATAL 11 0.0070
218 BRAIN HYPOXIA 7 0.0070
219 PULSE ABSENT 33 0.0069
220 ATRIOVENTRICULAR BLOCK SECOND DEGREE 21 0.0069
221 APALLIC SYNDROME 5 0.0069
222 NODAL RHYTHM 10 0.0068
223 CLONIC CONVULSION 5 0.0068
224 HYPOVOLAEMIA 40 0.0068
225 CONJUNCTIVAL OEDEMA 7 0.0068
226 ELECTROCARDIOGRAM T WAVE INVERSION 15 0.0068
227 COGWHEEL RIGIDITY 7 0.0067
228 ADRENOCORTICAL INSUFFICIENCY ACUTE 13 0.0067
229 PRODUCT PACKAGING CONFUSION 16 0.0066
230 PARALYSIS 94 0.0066
231 OCULOGYRIC CRISIS 14 0.0065
232 BLOOD PH DECREASED 11 0.0064
233 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 5 0.0064
234 ELECTROENCEPHALOGRAM ABNORMAL 20 0.0063
235 MECHANICAL VENTILATION 12 0.0063
236 SEDATION COMPLICATION 16 0.0063
237 BLOOD PRESSURE SYSTOLIC DECREASED 28 0.0061
238 RESPIRATORY ALKALOSIS 10 0.0061
239 VOCAL CORD PARALYSIS 11 0.0061
240 PROCEDURAL COMPLICATION 47 0.0061
241 STRIDOR 18 0.0061
242 NEONATAL HYPOXIA 5 0.0060
243 MUCOSAL HAEMORRHAGE 7 0.0060
244 DYSCHROMATOPSIA 5 0.0060
245 FUNGAL SEPSIS 5 0.0060
246 SHOCK HAEMORRHAGIC 49 0.0060
247 MUSCLE RIGIDITY 71 0.0059
248 PROCEDURAL HAEMORRHAGE 23 0.0059
249 PRODUCT CONTAMINATION MICROBIAL 7 0.0059
250 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 9 0.0059
251 ATRIOVENTRICULAR BLOCK COMPLETE 39 0.0058
252 ATELECTASIS 56 0.0058
253 HYPOTENSION 1158 0.0058
254 ENDOCRINE OPHTHALMOPATHY 5 0.0058
255 VENTRICULAR ARRHYTHMIA 21 0.0057
256 INHIBITORY DRUG INTERACTION 9 0.0057
257 LARYNGEAL OEDEMA 35 0.0057
258 SUPRAVENTRICULAR EXTRASYSTOLES 19 0.0056
259 VOCAL CORD DISORDER 11 0.0056
260 BRADYCARDIA NEONATAL 7 0.0056
261 VASODILATATION 14 0.0056
262 RIGHT VENTRICULAR HYPERTROPHY 5 0.0055
263 LEFT ATRIAL DILATATION 7 0.0055
264 EXTENSOR PLANTAR RESPONSE 5 0.0054
265 LONG QT SYNDROME 13 0.0054
266 PREMATURE DELIVERY 84 0.0053
267 CHOREA 9 0.0052
268 WRONG PRODUCT ADMINISTERED 35 0.0052
269 CROSS SENSITIVITY REACTION 5 0.0051
270 RESTRICTIVE PULMONARY DISEASE 6 0.0051
271 PERITONEAL HAEMORRHAGE 7 0.0050
272 ANORECTAL DISORDER 10 0.0050
273 ADMINISTRATION SITE EXTRAVASATION 5 0.0050
274 MAST CELL ACTIVATION SYNDROME 7 0.0050
275 DEVICE RELATED SEPSIS 10 0.0050
276 PRIAPISM 17 0.0049
277 VASCULAR STENT THROMBOSIS 10 0.0049
278 HYPOPNOEA 17 0.0049
279 TACHYCARDIA 435 0.0049
280 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 25 0.0049
281 OXYGEN SATURATION DECREASED 273 0.0049
282 DISTRIBUTIVE SHOCK 11 0.0049
283 PREMATURE BABY 146 0.0048
284 TACHYARRHYTHMIA 12 0.0048
285 TROPONIN I INCREASED 8 0.0048
286 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
287 RESPIRATORY ARREST 132 0.0048
288 LOW BIRTH WEIGHT BABY 38 0.0048
289 BLOOD PHOSPHORUS INCREASED 13 0.0048
290 TYPE IV HYPERSENSITIVITY REACTION 13 0.0047
291 BRONCHIAL SECRETION RETENTION 6 0.0047
292 RASH MORBILLIFORM 13 0.0047
293 PNEUMOTHORAX 74 0.0047
294 SINUS BRADYCARDIA 45 0.0047
295 LUNG CONSOLIDATION 13 0.0046
296 ANGIOPATHY 26 0.0046
297 CONVERSION DISORDER 9 0.0046
298 LANGUAGE DISORDER 10 0.0046
299 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 28 0.0046
300 CARDIOGENIC SHOCK 66 0.0046
301 EXTRADURAL HAEMATOMA 6 0.0045
302 PERIRECTAL ABSCESS 5 0.0045
303 BLOOD LACTATE DEHYDROGENASE INCREASED 71 0.0045
304 POTENTIATING DRUG INTERACTION 15 0.0045
305 TONGUE OEDEMA 17 0.0045
306 HYPOTHERMIA 45 0.0044
307 HYPERNATRAEMIA 22 0.0044
308 SUPRAVENTRICULAR TACHYCARDIA 42 0.0044
309 QUADRIPLEGIA 9 0.0044
310 HEAD TITUBATION 6 0.0044
311 VENTRICULAR HYPOKINESIA 14 0.0044
312 PARADOXICAL DRUG REACTION 16 0.0043
313 COVID-19 PNEUMONIA 51 0.0043
314 BLOOD POTASSIUM INCREASED 70 0.0043
315 LIVEDO RETICULARIS 9 0.0043
316 CARDIOVASCULAR INSUFFICIENCY 7 0.0043
317 CARDIAC DYSFUNCTION 16 0.0043
318 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
319 HYPERTENSIVE CRISIS 47 0.0042
320 INTENSIVE CARE 6 0.0042
321 SHOCK 97 0.0042
322 COMPARTMENT SYNDROME 11 0.0042
323 CEREBELLAR HAEMORRHAGE 6 0.0042
324 HEART VALVE INCOMPETENCE 12 0.0042
325 AREFLEXIA 11 0.0041
326 GAZE PALSY 7 0.0041
327 HYPOTONIA 41 0.0041
328 HYPERLACTACIDAEMIA 11 0.0041
329 BRADYPNOEA 11 0.0041
330 MULTIPLE ORGAN DYSFUNCTION SYNDROME 115 0.0041
331 HYPERVOLAEMIA 20 0.0040
332 HEART INJURY 10 0.0040
333 LIP OEDEMA 17 0.0040
334 CATHETER SITE HAEMORRHAGE 10 0.0040
335 BLOOD LACTIC ACID INCREASED 21 0.0040
336 COMPLICATIONS OF TRANSPLANTED KIDNEY 9 0.0040
337 NEONATAL RESPIRATORY DISTRESS SYNDROME 14 0.0040
338 HYPERTHERMIA 30 0.0039
339 METHAEMOGLOBINAEMIA 9 0.0039
340 ATRIOVENTRICULAR BLOCK 30 0.0039
341 PNEUMOMEDIASTINUM 7 0.0039
342 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 30 0.0039
343 SLOW RESPONSE TO STIMULI 5 0.0039
344 TACHYPNOEA 52 0.0038
345 SINUS NODE DYSFUNCTION 7 0.0038
346 CONDUCTION DISORDER 7 0.0038
347 PNEUMOPERITONEUM 7 0.0038
348 ACUTE RESPIRATORY DISTRESS SYNDROME 67 0.0038
349 MULTI-ORGAN FAILURE 65 0.0038
350 RESPIRATORY FAILURE 272 0.0037
351 STARING 9 0.0037
352 METABOLIC ACIDOSIS 118 0.0037
353 BRAIN HERNIATION 11 0.0037
354 FACE OEDEMA 62 0.0037
355 VENTRICULAR EXTRASYSTOLES 38 0.0037
356 NEUROLEPTIC MALIGNANT SYNDROME 43 0.0036
357 DRUG LEVEL BELOW THERAPEUTIC 20 0.0036
358 TRAUMATIC LUNG INJURY 7 0.0036
359 BRAIN OEDEMA 45 0.0036
360 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 34 0.0036
361 BRAIN DEATH 11 0.0036
362 FEAR OF DEATH 8 0.0036
363 HYPERAEMIA 7 0.0035
364 ANGLE CLOSURE GLAUCOMA 9 0.0035
365 RESPIRATORY RATE DECREASED 11 0.0035
366 LEFT VENTRICULAR FAILURE 12 0.0035
367 DRUG EFFECT INCREASED 11 0.0035
368 CORONARY ARTERY THROMBOSIS 7 0.0035
369 OSTEOLYSIS 7 0.0034
370 FOOD INTERACTION 6 0.0034
371 GENERALISED TONIC-CLONIC SEIZURE 56 0.0034
372 SINUS TACHYCARDIA 48 0.0034
373 MYOCARDIAL ISCHAEMIA 38 0.0033
374 POST PROCEDURAL COMPLICATION 64 0.0033
375 HYDROCEPHALUS 18 0.0033
376 DYSTONIA 64 0.0033
377 MYOCLONIC EPILEPSY 5 0.0033
378 HYPERKALAEMIA 115 0.0033
379 STATUS EPILEPTICUS 37 0.0033
380 PATENT DUCTUS ARTERIOSUS 13 0.0033
381 PERIORBITAL OEDEMA 17 0.0033
382 BLOOD PRESSURE IMMEASURABLE 5 0.0033
383 PULMONARY OEDEMA 146 0.0033
384 AZOTAEMIA 13 0.0033
385 ORAL MUCOSAL ERUPTION 5 0.0033
386 HEPATITIS ACUTE 21 0.0032
387 NYSTAGMUS 17 0.0032
388 BLOOD CREATINE PHOSPHOKINASE INCREASED 92 0.0032
389 EXTRAVASATION 13 0.0032
390 RHABDOMYOLYSIS 131 0.0031
391 ACUTE RESPIRATORY FAILURE 60 0.0031
392 MYOCLONUS 37 0.0031
393 TRISMUS 16 0.0031
394 EMPHYSEMA 31 0.0031
395 HEPATITIS TOXIC 8 0.0031
396 DEAFNESS NEUROSENSORY 10 0.0030
397 MYDRIASIS 39 0.0030
398 BLOOD PRESSURE DECREASED 201 0.0030
399 ANURIA 26 0.0030
400 QUADRIPARESIS 5 0.0030
401 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 8 0.0030
402 DRUG INTERACTION 476 0.0030
403 MONOPLEGIA 13 0.0030
404 ANGIOEDEMA 132 0.0030
405 POST PROCEDURAL HAEMATOMA 5 0.0030
406 NORMAL NEWBORN 16 0.0029
407 INTRA-ABDOMINAL HAEMORRHAGE 7 0.0029
408 POLYCYTHAEMIA 6 0.0029
409 PREMATURE RUPTURE OF MEMBRANES 7 0.0029
410 BLOOD ALBUMIN DECREASED 23 0.0029
411 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 17 0.0029
412 ACUTE PULMONARY OEDEMA 16 0.0028
413 STAPHYLOCOCCUS TEST POSITIVE 6 0.0028
414 CONTRAINDICATED PRODUCT ADMINISTERED 86 0.0028
415 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
416 UNRESPONSIVE TO STIMULI 72 0.0028
417 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
418 COMA SCALE ABNORMAL 8 0.0028
419 ESSENTIAL HYPERTENSION 5 0.0027
420 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 69 0.0027
421 URINE OUTPUT DECREASED 23 0.0026
422 HYPERTONIA 15 0.0026
423 RESPIRATORY DISTRESS 72 0.0026
424 INTRACARDIAC THROMBUS 8 0.0026
425 HAEMOLYTIC URAEMIC SYNDROME 6 0.0026
426 CARDIO-RESPIRATORY ARREST 108 0.0026
427 LEFT VENTRICULAR HYPERTROPHY 11 0.0026
428 CYANOSIS 40 0.0025
429 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
430 UNDERWEIGHT 5 0.0025
431 GUILLAIN-BARRE SYNDROME 12 0.0025
432 BLOOD IMMUNOGLOBULIN E INCREASED 6 0.0025
433 MUSCLE TWITCHING 57 0.0025
434 FOETAL EXPOSURE DURING PREGNANCY 201 0.0025
435 EAR HAEMORRHAGE 5 0.0025
436 DERMATITIS ALLERGIC 31 0.0025
437 SUBSTANCE ABUSE 20 0.0025
438 RETROPERITONEAL HAEMORRHAGE 6 0.0024
439 HYPERPARATHYROIDISM 5 0.0024
440 ACUTE CORONARY SYNDROME 20 0.0024
441 POST PROCEDURAL HAEMORRHAGE 28 0.0024
442 ELECTROCARDIOGRAM QT PROLONGED 85 0.0024
443 FOETAL DISTRESS SYNDROME 5 0.0024
444 ACUTE HEPATIC FAILURE 32 0.0023
445 NORMOCHROMIC NORMOCYTIC ANAEMIA 7 0.0023
446 SPINAL CORD COMPRESSION 9 0.0023
447 PULMONARY HAEMORRHAGE 18 0.0023
448 THERAPEUTIC PRODUCT EFFECT DECREASED 103 0.0023
449 RIGHT VENTRICULAR FAILURE 16 0.0023
450 LUNG OPACITY 6 0.0023
451 CHOLESTATIC LIVER INJURY 5 0.0022
452 ILEUS PARALYTIC 10 0.0022
453 PRODUCT LABEL CONFUSION 13 0.0022
454 ALTERED STATE OF CONSCIOUSNESS 48 0.0022
455 POLYURIA 18 0.0022
456 NEPHROGENIC ANAEMIA 10 0.0022
457 RASH MACULO-PAPULAR 47 0.0021
458 GENERALISED ERYTHEMA 12 0.0021
459 HYPOVOLAEMIC SHOCK 10 0.0021
460 FEAR 56 0.0021
461 COAGULOPATHY 34 0.0020
462 HEPATITIS FULMINANT 6 0.0020
463 RENAL INJURY 60 0.0020
464 HYPERPARATHYROIDISM SECONDARY 5 0.0020
465 BRAIN INJURY 20 0.0020
466 MIXED LIVER INJURY 6 0.0020
467 VENTRICULAR HYPERTROPHY 5 0.0020
468 NECROTISING FASCIITIS 7 0.0020
469 ADVERSE REACTION 26 0.0020
470 DRUG EFFECT LESS THAN EXPECTED 29 0.0020
471 ELECTROCARDIOGRAM ABNORMAL 15 0.0019
472 EYELID OEDEMA 22 0.0019
473 CAESAREAN SECTION 22 0.0019
474 OBSTRUCTIVE AIRWAYS DISORDER 21 0.0019
475 PNEUMONIA VIRAL 6 0.0019
476 PRODUCT ADMINISTRATION ERROR 38 0.0019
477 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0018
478 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
479 HEPARIN-INDUCED THROMBOCYTOPENIA 9 0.0018
480 ALANINE AMINOTRANSFERASE INCREASED 112 0.0018
481 BODY TEMPERATURE INCREASED 37 0.0018
482 PALLOR 49 0.0018
483 WRONG DRUG ADMINISTERED 16 0.0018
484 INTRACRANIAL PRESSURE INCREASED 10 0.0018
485 WOUND DEHISCENCE 6 0.0018
486 PREMATURE LABOUR 10 0.0018
487 INFUSION SITE EXTRAVASATION 11 0.0018
488 MITRAL VALVE INCOMPETENCE 20 0.0018
489 CHOLECYSTITIS ACUTE 10 0.0018
490 OXYGEN SATURATION ABNORMAL 5 0.0018
491 PHLEBITIS 9 0.0018
492 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
493 RESPIRATION ABNORMAL 12 0.0017
494 LOCALISED OEDEMA 8 0.0017
495 URTICARIA 287 0.0017
496 SEPTIC SHOCK 74 0.0017
497 JAUNDICE CHOLESTATIC 6 0.0017
498 LUNG INFILTRATION 15 0.0017
499 DYSKINESIA 69 0.0017
500 GENERALISED OEDEMA 21 0.0017
501 EUGLYCAEMIC DIABETIC KETOACIDOSIS 7 0.0017
502 RESPIRATORY RATE INCREASED 15 0.0017
503 TENDON DISORDER 11 0.0017
504 ANHEDONIA 44 0.0017
505 MATERNAL EXPOSURE DURING PREGNANCY 147 0.0016
506 ASPIRATION 18 0.0016
507 HYPERBILIRUBINAEMIA 17 0.0016
508 EXPOSURE DURING PREGNANCY 102 0.0016
509 NO THERAPEUTIC RESPONSE 20 0.0016
510 ATRIAL FLUTTER 13 0.0016
511 MIOSIS 13 0.0016
512 DELIRIUM 56 0.0016
513 OLIGURIA 10 0.0016
514 CORONARY ARTERY STENOSIS 8 0.0016
515 EXTRASYSTOLES 11 0.0016
516 PORTAL VEIN THROMBOSIS 5 0.0015
517 DRUG EFFECT DELAYED 7 0.0015
518 CARDIOPULMONARY FAILURE 6 0.0015
519 COMA 73 0.0015
520 RENAL TUBULAR NECROSIS 15 0.0015
521 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
522 CARDIAC FAILURE ACUTE 10 0.0015
523 CARDIOMYOPATHY 22 0.0015
524 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
525 ENCEPHALOPATHY 36 0.0015
526 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
527 HYPERAESTHESIA 12 0.0015
528 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
529 STILLBIRTH 7 0.0014
530 PNEUMONIA ASPIRATION 36 0.0014
531 RESPIRATORY DISORDER 43 0.0014
532 MATERNAL DRUGS AFFECTING FOETUS 11 0.0014
533 BREATH SOUNDS ABNORMAL 7 0.0014
534 HYPERPYREXIA 6 0.0014
535 FIBRIN D DIMER INCREASED 5 0.0014
536 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
537 TOXIC SKIN ERUPTION 14 0.0014
538 LEUKOCYTOSIS 25 0.0014
539 RALES 8 0.0014
540 ELECTROLYTE IMBALANCE 16 0.0014
541 SCLERODERMA 5 0.0014
542 MOTOR DYSFUNCTION 14 0.0014
543 DYSPHEMIA 6 0.0014
544 HYPOMAGNESAEMIA 19 0.0014
545 THROMBOCYTOSIS 5 0.0014
546 HEMIPARESIS 23 0.0014
547 THROMBOTIC MICROANGIOPATHY 13 0.0013
548 PROTEIN TOTAL DECREASED 5 0.0013
549 RENAL FAILURE ACUTE 56 0.0013
550 TOXIC EPIDERMAL NECROLYSIS 20 0.0013
551 DERMATITIS ACNEIFORM 8 0.0013
552 PLEURAL EFFUSION 80 0.0013
553 HAEMATOMA 34 0.0013
554 HAEMODIALYSIS 11 0.0013
555 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
556 ANAL ABSCESS 7 0.0013
557 PULMONARY CONGESTION 17 0.0013
558 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 7 0.0013
559 HYPOALBUMINAEMIA 10 0.0013
560 WOUND SECRETION 5 0.0013
561 CHOLECYSTITIS 15 0.0013
562 KIDNEY TRANSPLANT REJECTION 6 0.0012
563 RENAL IMPAIRMENT 105 0.0012
564 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
565 DRUG EFFECT DECREASED 66 0.0012
566 HEPATOMEGALY 12 0.0012
567 MUCOUS STOOLS 6 0.0012
568 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
569 PNEUMONIA BACTERIAL 11 0.0012
570 AGITATION 88 0.0012
571 RENAL FAILURE 156 0.0012
572 TRANSAMINASES INCREASED 26 0.0012
573 RASH GENERALISED 30 0.0012
574 DRUG LEVEL INCREASED 19 0.0011
575 DRUG-INDUCED LIVER INJURY 36 0.0011
576 PULMONARY FUNCTION TEST DECREASED 5 0.0011
577 HEPATIC FUNCTION ABNORMAL 42 0.0011
578 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0011
579 SCREAMING 7 0.0011
580 ACUTE KIDNEY INJURY 166 0.0011
581 GRAND MAL CONVULSION 10 0.0011
582 LACTIC ACIDOSIS 35 0.0011
583 SUBARACHNOID HAEMORRHAGE 11 0.0011
584 NECROSIS 6 0.0011
585 LIVE BIRTH 9 0.0011
586 CARDIAC TAMPONADE 5 0.0011
587 ILEUS 13 0.0010
588 FAECAL INCONTINENCE 5 0.0010
589 RENAL FAILURE CHRONIC 8 0.0010
590 SEPSIS 116 0.0010
591 HEART RATE DECREASED 36 0.0010
592 ACUTE MYOCARDIAL INFARCTION 30 0.0010
593 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
594 DRUG RESISTANCE 26 0.0010
595 INJURY 71 0.0010
596 HAEMOLYTIC ANAEMIA 9 0.0010
597 HYPOCALCAEMIA 19 0.0010
598 STEVENS-JOHNSON SYNDROME 22 0.0010
599 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
600 LIVER FUNCTION TEST INCREASED 21 0.0010
601 HAEMOPTYSIS 27 0.0010
602 DERMATITIS BULLOUS 7 0.0010
603 ERYTHEMA MULTIFORME 9 0.0010
604 PULMONARY HYPERTENSION 20 0.0010
605 THERAPY NON-RESPONDER 43 0.0010
606 BLOOD UREA INCREASED 16 0.0010
607 CATATONIA 5 0.0010
608 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
609 CYTOKINE RELEASE SYNDROME 19 0.0009
610 HYPOPHOSPHATAEMIA 7 0.0009
611 HAEMATEMESIS 24 0.0009
612 ABSCESS LIMB 4 0.0009
613 ARTHROPATHY 52 0.0009
614 KETOACIDOSIS 7 0.0009
615 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
616 HYPOKALAEMIA 43 0.0009
617 JAUNDICE 25 0.0009
618 SWOLLEN TONGUE 29 0.0009
619 BACTERAEMIA 11 0.0009
620 HIATUS HERNIA 12 0.0009
621 SKIN REACTION 13 0.0009
622 DIALYSIS 13 0.0009
623 JAW DISORDER 5 0.0009
624 ERYTHEMA 187 0.0009
625 HAEMOLYSIS 7 0.0009
626 TREATMENT FAILURE 75 0.0009
627 PURPURA 8 0.0009
628 RESTLESSNESS 33 0.0009
629 CEREBRAL INFARCTION 22 0.0009
630 MENTAL STATUS CHANGES 25 0.0009
631 RASH ERYTHEMATOUS 43 0.0009
632 HEART RATE ABNORMAL 5 0.0009
633 WHEEZING 53 0.0009
634 CHROMATURIA 20 0.0009
635 UNEVALUABLE EVENT 67 0.0009
636 RENAL CYST 7 0.0009
637 DRUG INEFFECTIVE 1155 0.0009
638 UROSEPSIS 8 0.0009
639 MYASTHENIA GRAVIS 7 0.0009
640 LARGE INTESTINE PERFORATION 6 0.0009
641 HYPERTRIGLYCERIDAEMIA 5 0.0009
642 ATRIAL FIBRILLATION 82 0.0008
643 HAEMORRHAGE 88 0.0008
644 EJECTION FRACTION DECREASED 13 0.0008
645 TOXICITY TO VARIOUS AGENTS 141 0.0008
646 DRUG USE DISORDER 7 0.0008
647 CARDIOVASCULAR DISORDER 21 0.0008
648 ADRENAL INSUFFICIENCY 10 0.0008
649 HYPERGLYCAEMIA 30 0.0008
650 MOUTH HAEMORRHAGE 6 0.0008
651 PHARYNGEAL SWELLING 8 0.0008
652 ABSCESS 13 0.0008
653 DRUG TOXICITY 11 0.0008
654 ARRHYTHMIA 38 0.0008
655 BLOOD CALCIUM DECREASED 9 0.0008
656 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
657 NEUROTOXICITY 14 0.0008
658 BLOOD CALCIUM INCREASED 7 0.0008
659 PRODUCT COMPLAINT 20 0.0008
660 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
661 OCCUPATIONAL EXPOSURE TO PRODUCT 5 0.0008
662 BLOOD BILIRUBIN INCREASED 21 0.0008
663 POOR QUALITY DRUG ADMINISTERED 5 0.0008
664 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
665 FLUSHING 78 0.0008
666 HEPATIC FAILURE 23 0.0008
667 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
668 HEART RATE INCREASED 75 0.0008
669 HEPATIC ENCEPHALOPATHY 7 0.0007
670 NEPHROPATHY 7 0.0007
671 ANAL FISSURE 4 0.0007
672 SENSORY LOSS 6 0.0007
673 POSTOPERATIVE WOUND INFECTION 5 0.0007
674 EYE MOVEMENT DISORDER 5 0.0007
675 ECCHYMOSIS 5 0.0007
676 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 40 0.0007
677 PRODUCT QUALITY ISSUE 99 0.0007
678 HYPERTENSION 154 0.0007
679 LIP SWELLING 24 0.0007
680 URINARY RETENTION 24 0.0007
681 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 51 0.0007
682 HYPERSENSITIVITY 131 0.0007
683 HEPATOCELLULAR INJURY 10 0.0007
684 BLOOD CREATININE INCREASED 46 0.0007
685 OEDEMA 38 0.0007
686 HYPOKINESIA 10 0.0007
687 FLUID OVERLOAD 10 0.0007
688 EPILEPSY 21 0.0007
689 EXTRAPYRAMIDAL DISORDER 17 0.0007
690 MEDICATION ERROR 38 0.0007
691 RASH 297 0.0007
692 CARDIOTOXICITY 6 0.0007
693 HYPERLIPIDAEMIA 8 0.0007
694 CONDITION AGGRAVATED 203 0.0007
695 AKATHISIA 9 0.0007
696 ACCIDENTAL OVERDOSE 24 0.0007
697 CARDIOMEGALY 8 0.0006
698 DEVICE RELATED INFECTION 10 0.0006
699 ASPARTATE AMINOTRANSFERASE INCREASED 34 0.0006
700 TRICUSPID VALVE INCOMPETENCE 5 0.0006
701 NEPHROPATHY TOXIC 7 0.0006
702 SEIZURE 72 0.0006
703 PARKINSONISM 6 0.0006
704 EPISTAXIS 46 0.0006
705 CEREBRAL HAEMORRHAGE 22 0.0006
706 SWELLING FACE 40 0.0006
707 DERMATITIS CONTACT 7 0.0006
708 DECUBITUS ULCER 5 0.0006
709 MYOCARDITIS 7 0.0006
710 THERAPY CHANGE 6 0.0006
711 EMBOLISM 5 0.0006
712 NEUTROPHIL COUNT INCREASED 6 0.0006
713 DYSARTHRIA 22 0.0006
714 HYPERHIDROSIS 75 0.0006
715 PULMONARY EMBOLISM 55 0.0006
716 CARDIAC MURMUR 5 0.0006
717 SLEEP APNOEA SYNDROME 11 0.0006
718 TRANSFUSION 6 0.0006
719 EMOTIONAL DISTRESS 69 0.0006
720 MUSCLE SPASTICITY 7 0.0006
721 HYPERCALCAEMIA 7 0.0006
722 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
723 APHASIA 17 0.0006
724 OVERDOSE 121 0.0006
725 MYOSITIS 5 0.0006
726 DRUG EFFECT INCOMPLETE 20 0.0006
727 LIVER FUNCTION TEST ABNORMAL 16 0.0005
728 FLATULENCE 31 0.0005
729 ASCITES 16 0.0005
730 THERAPEUTIC RESPONSE SHORTENED 18 0.0005
731 MALNUTRITION 6 0.0005
732 APPENDICITIS 5 0.0005
733 HAEMORRHAGE INTRACRANIAL 8 0.0005
734 INTESTINAL PERFORATION 6 0.0005
735 ABORTION INDUCED 5 0.0005
736 REBOUND EFFECT 6 0.0005
737 DISORIENTATION 21 0.0005
738 DRUG EXPOSURE DURING PREGNANCY 18 0.0005
739 ECONOMIC PROBLEM 8 0.0005
740 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
741 RECALLED PRODUCT ADMINISTERED 5 0.0005
742 PHARYNGEAL OEDEMA 8 0.0005
743 IMPAIRED GASTRIC EMPTYING 7 0.0005
744 CARDIAC FAILURE 41 0.0005
745 LYMPHOCYTE COUNT DECREASED 9 0.0005
746 FAECES DISCOLOURED 11 0.0005
747 ATAXIA 6 0.0005
748 OBESITY 8 0.0005
749 WITHDRAWAL SYNDROME 21 0.0005
750 BLOOD PRESSURE FLUCTUATION 12 0.0005
751 MELAENA 11 0.0005
752 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
753 HEPATOTOXICITY 11 0.0005
754 END STAGE RENAL DISEASE 9 0.0005
755 LOSS OF CONSCIOUSNESS 63 0.0005
756 LIVER INJURY 12 0.0005
757 OFF LABEL USE 428 0.0005
758 PRODUCT USE IN UNAPPROVED INDICATION 121 0.0005
759 STAPHYLOCOCCAL INFECTION 16 0.0005
760 HEPATIC STEATOSIS 9 0.0005
761 PERIPHERAL SWELLING 73 0.0005
762 CANDIDA INFECTION 8 0.0005
763 CHOLESTASIS 9 0.0005
764 DYSPHONIA 27 0.0005
765 SEDATION 12 0.0005
766 ORAL CANDIDIASIS 6 0.0005
767 DISABILITY 9 0.0005
768 SARS-COV-2 TEST POSITIVE 6 0.0005
769 HAEMATOCRIT DECREASED 9 0.0005
770 DYSPHAGIA 42 0.0004
771 C-REACTIVE PROTEIN INCREASED 16 0.0004
772 BONE DISORDER 8 0.0004
773 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
774 MUSCLE TIGHTNESS 7 0.0004
775 BLOOD PRESSURE INCREASED 66 0.0004
776 MUSCULAR WEAKNESS 49 0.0004
777 PAIN IN JAW 12 0.0004
778 HYPERTHYROIDISM 6 0.0004
779 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
780 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
781 DRUG WITHDRAWAL SYNDROME NEONATAL 6 0.0004
782 LOCAL SWELLING 7 0.0004
783 AGGRESSION 20 0.0004
784 POISONING 5 0.0004
785 PROCEDURAL PAIN 11 0.0004
786 DRUG ADMINISTRATION ERROR 12 0.0004
787 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
788 RASH PRURITIC 21 0.0004
789 DRUG WITHDRAWAL SYNDROME 34 0.0004
790 LIVER DISORDER 17 0.0004
791 GASTROINTESTINAL HAEMORRHAGE 32 0.0004
792 LETHARGY 22 0.0004
793 HAEMOGLOBIN DECREASED 39 0.0004
794 PLATELET COUNT DECREASED 40 0.0004
795 RETCHING 8 0.0004
796 BACTERIAL INFECTION 7 0.0004
797 LUNG DISORDER 18 0.0004
798 HEPATIC ENZYME INCREASED 25 0.0004
799 THROMBOCYTOPENIA 41 0.0004
800 THERAPEUTIC RESPONSE DECREASED 22 0.0004
801 COMPLETED SUICIDE 30 0.0004
802 PARAESTHESIA 56 0.0004
803 HYPONATRAEMIA 20 0.0004
804 BLINDNESS UNILATERAL 5 0.0004
805 PNEUMONIA 114 0.0004
806 HYPOPHAGIA 9 0.0004
807 HAEMATURIA 12 0.0004
808 SUBDURAL HAEMATOMA 5 0.0003
809 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
810 MUCOSAL INFLAMMATION 9 0.0003
811 INTENTIONAL OVERDOSE 22 0.0003
812 EOSINOPHILIA 6 0.0003
813 ANXIETY 97 0.0003
814 RIB FRACTURE 7 0.0003
815 DRUG ERUPTION 6 0.0003
816 DEEP VEIN THROMBOSIS 22 0.0003
817 DYSPNOEA 190 0.0003
818 CONVULSION 19 0.0003
819 INTENTIONAL PRODUCT MISUSE 29 0.0003
820 DEVICE FAILURE 5 0.0003
821 PYREXIA 113 0.0003
822 LYMPHOMA 5 0.0003
823 EXTRA DOSE ADMINISTERED 13 0.0003
824 FEBRILE NEUTROPENIA 21 0.0003
825 CHRONIC KIDNEY DISEASE 24 0.0003
826 CONFUSIONAL STATE 51 0.0003
827 SENSORY DISTURBANCE 5 0.0003
828 PRESCRIBED OVERDOSE 6 0.0003
829 SWELLING 29 0.0003
830 DIPLOPIA 8 0.0003
831 CHILLS 36 0.0003
832 CHOLELITHIASIS 10 0.0003
833 PSYCHOTIC DISORDER 9 0.0003
834 METASTASES TO BONE 5 0.0003
835 PRODUCT USE ISSUE 57 0.0003
836 SOMNOLENCE 61 0.0003
837 PERICARDIAL EFFUSION 7 0.0003
838 CYTOMEGALOVIRUS INFECTION 5 0.0003
839 BLOOD POTASSIUM DECREASED 9 0.0003
840 CARDIAC DISORDER 28 0.0003
841 CELLULITIS 15 0.0003
842 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
843 MYOCARDIAL INFARCTION 51 0.0003
844 INTESTINAL OBSTRUCTION 11 0.0003
845 INFLAMMATION 15 0.0003
846 HYPOGLYCAEMIA 14 0.0003
847 PANCYTOPENIA 16 0.0003
848 HALLUCINATION, VISUAL 6 0.0003
849 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
850 HYPOTHYROIDISM 9 0.0003
851 MOVEMENT DISORDER 9 0.0003
852 OSTEOMYELITIS 5 0.0003
853 MENTAL DISORDER 12 0.0003
854 PRODUCT PRESCRIBING ISSUE 6 0.0003
855 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
856 HEPATITIS 7 0.0003
857 BLOOD SODIUM DECREASED 5 0.0003
858 BLOOD URINE PRESENT 5 0.0003
859 SKIN DISCOLOURATION 12 0.0003
860 RASH MACULAR 9 0.0003
861 NERVOUS SYSTEM DISORDER 8 0.0003
862 COUGH 71 0.0003
863 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
864 ANAEMIA 48 0.0003
865 CRYING 9 0.0002
866 SUICIDE ATTEMPT 15 0.0002
867 FEEDING DISORDER 5 0.0002
868 DYSURIA 9 0.0002
869 ANGINA PECTORIS 7 0.0002
870 IMPAIRED HEALING 8 0.0002
871 PRODUCT SUBSTITUTION ISSUE 14 0.0002
872 OSTEONECROSIS OF JAW 6 0.0002
873 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
874 PERITONITIS 5 0.0002
875 TINNITUS 11 0.0002
876 DYSPNOEA EXERTIONAL 9 0.0002
877 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
878 PAIN 145 0.0002
879 COGNITIVE DISORDER 11 0.0002
880 RECTAL HAEMORRHAGE 10 0.0002
881 PRODUCT DISPENSING ERROR 5 0.0002
882 AMENORRHOEA 4 0.0002
883 THROMBOSIS 18 0.0002
884 PANCREATITIS ACUTE 5 0.0002
885 VOMITING 104 0.0002
886 PNEUMONITIS 6 0.0002
887 NO ADVERSE EVENT 39 0.0002
888 BLISTER 12 0.0002
889 OEDEMA PERIPHERAL 26 0.0002
890 SPEECH DISORDER 11 0.0002
891 MUSCULOSKELETAL STIFFNESS 18 0.0002
892 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
893 URINARY INCONTINENCE 6 0.0002
894 CHEST PAIN 37 0.0002
895 HAEMATOCHEZIA 11 0.0002
896 CARDIAC FAILURE CONGESTIVE 16 0.0002
897 FEMUR FRACTURE 6 0.0002
898 SKIN ULCER 5 0.0002
899 RENAL DISORDER 9 0.0002
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
901 ABDOMINAL DISTENSION 20 0.0002
902 GASTRITIS 5 0.0002
903 HEAD INJURY 6 0.0002
904 BACK PAIN 44 0.0002
905 PANCREATITIS 10 0.0002
906 OSTEOARTHRITIS 8 0.0002
907 NIGHT SWEATS 6 0.0002
908 HALLUCINATION 14 0.0002
909 CEREBROVASCULAR ACCIDENT 31 0.0002
910 ASTHENIA 68 0.0002
911 DRUG ABUSE 15 0.0002
912 LEUKOPENIA 9 0.0002
913 CHEST DISCOMFORT 18 0.0002
914 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
915 OROPHARYNGEAL PAIN 16 0.0002
916 NERVOUSNESS 9 0.0002
917 SURGERY 10 0.0002
918 OSTEOPOROSIS 7 0.0002
919 CONSTIPATION 37 0.0002
920 HYPOAESTHESIA 25 0.0002
921 DISTURBANCE IN ATTENTION 9 0.0002
922 FEELING HOT 10 0.0002
923 DEPRESSION 37 0.0002
924 EYE SWELLING 6 0.0002
925 PRODUCT STORAGE ERROR 14 0.0002
926 ASTHMA 18 0.0002
927 URINARY TRACT INFECTION 27 0.0002
928 TREMOR 26 0.0002
929 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
930 INCORRECT DOSE ADMINISTERED 35 0.0002
931 NEPHROLITHIASIS 7 0.0002
932 UNDERDOSE 11 0.0002
933 ABDOMINAL PAIN 35 0.0002
934 VIRAL INFECTION 5 0.0002
935 COVID-19 26 0.0001
936 DISCOMFORT 9 0.0001
937 BLINDNESS 6 0.0001
938 MYALGIA 25 0.0001
939 NAUSEA 114 0.0001
940 SYNCOPE 14 0.0001
941 NEUTROPENIA 19 0.0001
942 AMNESIA 9 0.0001
943 NEUROPATHY PERIPHERAL 13 0.0001
944 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
945 MUSCLE SPASMS 25 0.0001
946 NEUTROPHIL COUNT DECREASED 5 0.0001
947 DEATH 104 0.0001
948 GASTROINTESTINAL DISORDER 10 0.0001
949 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
950 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
951 DISEASE PROGRESSION 13 0.0001
952 BLOOD GLUCOSE INCREASED 20 0.0001
953 OCULAR HYPERAEMIA 5 0.0001
954 DIABETES MELLITUS 8 0.0001
955 MALAISE 44 0.0001
956 IRRITABILITY 6 0.0001
957 STOMATITIS 6 0.0001
958 DRY MOUTH 8 0.0001
959 THERAPY CESSATION 5 0.0001
960 INFECTION 14 0.0001
961 PRURITUS 37 0.0001
962 DIARRHOEA 60 0.0001
963 TREATMENT NONCOMPLIANCE 5 0.0001
964 FALL 30 0.0001
965 DEHYDRATION 12 0.0001
966 VISION BLURRED 12 0.0001
967 PALPITATIONS 10 0.0001
968 BONE PAIN 5 0.0001
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
970 ABDOMINAL PAIN UPPER 17 0.0001
971 ILL-DEFINED DISORDER 5 0.0001
972 DIZZINESS 40 0.0001
973 MEMORY IMPAIRMENT 11 0.0001
974 RHINORRHOEA 5 0.0001
975 ADVERSE EVENT 7 0.0001
976 WEIGHT DECREASED 21 0.0001
977 CONTUSION 7 0.0001
978 DYSPEPSIA 7 0.0001
979 DECREASED APPETITE 16 0.0001
980 INSOMNIA 18 0.0001
981 BRONCHITIS 5 0.0001
982 ADVERSE DRUG REACTION 6 0.0001
983 PAIN IN EXTREMITY 18 0.0001
984 SINUSITIS 6 0.0001
985 HEADACHE 36 0.0001
986 FATIGUE 43 0.0001
987 ABDOMINAL DISCOMFORT 9 0.0001
988 VISUAL IMPAIRMENT 6 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
990 GAIT DISTURBANCE 8 0.0000
991 ARTHRALGIA 15 0.0000
992 WEIGHT INCREASED 5 0.0000
993 INJECTION SITE PAIN 6 0.0000